2-methyl-2-[4-[[4-oxo-3-propan-2-yl-1-(2,4,6-trichlorophenyl)-5H-pyrazolo[3,4-d]pyrimidin-6-yl]methyl]phenoxy]propanoic acid | 452913-20-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: 2-methyl-2-[4-[[4-oxo-3-propan-2-yl-1-(2,4,6-trichlorophenyl)-5H-pyrazolo[3,4-d]pyrimidin-6-yl]methyl]phenoxy]propanoic acid
• CAS: 452913-20-1
• 化学式: C₂₅H₂₃Cl₃N₄O₄
• 分子量: 549.841
• InChiKey: UFMZSTUBYGBOJB-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.8
• 重原子数：
  36
• 可旋转键数：
  7
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.28
• 拓扑面积：
  106
• 氢给体数：
  2
• 氢受体数：
  6

反应信息

• 作为反应物：
  描述：

  2-methyl-2-[4-[[4-oxo-3-propan-2-yl-1-(2,4,6-trichlorophenyl)-5H-pyrazolo[3,4-d]pyrimidin-6-yl]methyl]phenoxy]propanoic acid 、 17-叠氮-3,6,9,12,15-五氧杂十七烷-1-胺 在 1-羟基苯并三唑 、 N,N-二异丙基乙胺 作用下， 以 DMF (N,N-dimethyl-formamide) 为溶剂， 反应 24.0h， 生成
  参考文献：
  名称：

  [EN] INHIBITORS OF CYCLIN-DEPENDENT KINASES, COMPOSITIONS AND USES RELATED THERETO
  [FR] INHIBITEURS DE KINASES DEPENDANT DES CYCLINES, COMPOSITIONS ET UTILISATIONS ASSOCIEES

  摘要：

  公开号：

  WO2004092139A3

文献信息

• Inhibitors of cyclin-dependent kinases, compositions and uses related thereto
  申请人：GPC Biotech, Inc.

  公开号：US20040266854A1

  公开（公告）日：2004-12-30

  The invention pertains to novel cyclin dependent kinase inhibitors (cdks) and specifically, but not exclusively, as inhibitors of cdk/cyclin complexes. As described herein, the inhibitors of this invention are capable of inhibiting the cell-cycle machinery and consequently may be useful in modulating cell-cycle progression, ultimately controlling cell growth and differentiation. Such compounds would be useful for treating subjects having disorders associated with excessive cell proliferation.

  这项发明涉及新型细胞周期依赖性激酶抑制剂（cdks），具体而言，但不仅限于作为cdk/cyclin复合物的抑制剂。如本文所述，本发明的抑制剂能够抑制细胞周期机制，因此可能有助于调节细胞周期进程，最终控制细胞生长和分化。这样的化合物对于治疗患有与过度细胞增殖相关的疾病的患者将会很有用。
• Three hybrid assay system
  申请人：——

  公开号：US20040043388A1

  公开（公告）日：2004-03-04

  The invention provides compositions and methods for isolating ligand binding polypeptides for a user-specified ligand, and for isolating small molecule ligands for a user-specified target polypeptide using an improved class of hybrid ligand compounds.

  本发明提供了一种用于分离用户指定的配体结合多肽的组合物和方法，以及使用改良的混合配体化合物分离用户指定的靶多肽的小分子配体的方法。
• THREE HYBRID ASSAY SYSTEM
  申请人：GPC Biotech AG

  公开号：EP1364212B1

  公开（公告）日：2011-02-02
• INHIBITORS OF CYCLIN-DEPENDENT KINASES, COMPOSITIONS AND USES RELATED THERETO
  申请人：Bockovich Nicholas

  公开号：US20090209530A1

  公开（公告）日：2009-08-20

  The invention pertains to novel cyclin dependent kinase inhibitors (cdks) and specifically, but not exclusively, as inhibitors of cdk/cyclin complexes. As described herein, the inhibitors of this invention are capable of inhibiting the cell-cycle machinery and consequently may be useful in modulating cell-cycle progression, ultimately controlling cell growth and differentiation. Such compounds would be useful for treating subjects having disorders associated with excessive cell proliferation.
• US7135550B2
  申请人：——

  公开号：US7135550B2

  公开（公告）日：2006-11-14